☆ 4.4 Article

COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis — California and New York, May–November 2021

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Related references

Note: Only part of the references are listed.
Article Immunology

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Natural Immunity and Protection Against the Delta Variant: A Retrospective Cohort Study

Priscilla Kim et al.

Summary: Infection with SARS-CoV-2 provides strong protection against reinfection with the Delta variant, and natural immunity from prior infection lasts for at least 13 months.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection
Article Medicine, General & Internal

Covid-19 Vaccine Effectiveness in New York State

Eli S. Rosenberg et al.

Summary: The effectiveness of the BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines in New York State from May to August 2021 was assessed. Initial protection was high, but there was a modest decline in effectiveness after the surge of the delta variant, especially among recipients aged 65 and older. However, protection against hospitalization remained high.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection
Article Health Care Sciences & Services

Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France

Rebecca Grant et al.

Summary: This study assesses the settings and activities associated with SARS-CoV-2 infection in the context of the Delta variant circulation in France. It also investigates the protection against symptomatic Delta infection. The study finds that bars and parties are associated with increased risk of infection for individuals under 40 years old, while daycare, kindergarten, primary school, and middle school attendance are associated with increased risk of infection for those aged 40 and older. The study also highlights reduced vaccine effectiveness against symptomatic Delta infections and the importance of reinforcing individual and public health measures in high-risk settings and activities.

LANCET REGIONAL HEALTH-EUROPE (2022)

Add to Collection
Article Public, Environmental & Occupational Health

Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021

Catherine H. Bozio et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection
Article Public, Environmental & Occupational Health

Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021

Alyson M. Cavanaugh et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection
Article Public, Environmental & Occupational Health

New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021

Eli S. Rosenberg et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection
Article Public, Environmental & Occupational Health

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

Wesley H. Self et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.